Unaudited Condensed Consolidated Statements of Changes in Equity - USD ($) $ in Thousands |
Previously Reported
Convertible Preferred Units
|
Previously Reported
Member Units, Voting
|
Previously Reported
Common Stock
|
Previously Reported
Additional Paid-in Capital
|
Previously Reported
Subscription Receivable
|
Previously Reported
Accumulated Deficit
|
Previously Reported
Members’ Deficit
|
Previously Reported |
Retroactive application of recapitalization
Convertible Preferred Units
|
Retroactive application of recapitalization
Member Units, Voting
|
Retroactive application of recapitalization
Common Stock
|
Retroactive application of recapitalization
Additional Paid-in Capital
|
Retroactive application of recapitalization
Subscription Receivable
|
Retroactive application of recapitalization
Accumulated Deficit
|
Retroactive application of recapitalization
Members’ Deficit
|
Retroactive application of recapitalization |
Convertible Preferred Units |
Member Units, Voting |
Common Stock |
Additional Paid-in Capital |
Subscription Receivable |
Accumulated Deficit |
Members’ Deficit |
Equity-classified CPU Share Allocation |
Accumulated Other Comprehensive Income |
Total EMAT Stockholders' Equity |
Noncontrolling Interest |
Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at Dec. 31, 2024 | $ 9,587 | $ 306 | $ (60,892) | $ (50,999) | $ 45 | $ (45) | $ 50,999 | $ (50,999) | $ 9,587 | $ 45 | $ 261 | $ (60,892) | $ (50,999) | |||||||||||||||
| Balance (in Shares) at Dec. 31, 2024 | 35,230,021 | 1,000,000 | (1,000,000) | 454,712,290 | 35,230,021 | 454,712,290 | ||||||||||||||||||||||
| Issuance of convertible preferred units | $ 2,750 | (1,500) | 1,250 | |||||||||||||||||||||||||
| Issuance of convertible preferred units (in Shares) | 7,050,000 | |||||||||||||||||||||||||||
| Investor loan advances and deemed contributions | (853) | (853) | ||||||||||||||||||||||||||
| Net loss | (17,996) | (17,996) | ||||||||||||||||||||||||||
| Balance at Mar. 31, 2025 | $ 12,337 | $ 45 | (592) | (1,500) | (78,888) | (68,598) | ||||||||||||||||||||||
| Balance (in Shares) at Mar. 31, 2025 | 42,280,021 | 454,712,290 | ||||||||||||||||||||||||||
| Balance at Dec. 31, 2024 | $ 9,587 | $ 306 | $ (60,892) | $ (50,999) | $ 45 | $ (45) | $ 50,999 | $ (50,999) | $ 9,587 | $ 45 | 261 | (60,892) | (50,999) | |||||||||||||||
| Balance (in Shares) at Dec. 31, 2024 | 35,230,021 | 1,000,000 | (1,000,000) | 454,712,290 | 35,230,021 | 454,712,290 | ||||||||||||||||||||||
| Net loss | (58,225) | (58,887) | ||||||||||||||||||||||||||
| Balance at Jun. 30, 2025 | $ 12,337 | $ 45 | (324) | (119,779) | (107,721) | |||||||||||||||||||||||
| Balance (in Shares) at Jun. 30, 2025 | 42,280,021 | 454,712,290 | ||||||||||||||||||||||||||
| Balance at Mar. 31, 2025 | $ 12,337 | $ 45 | (592) | (1,500) | (78,888) | (68,598) | ||||||||||||||||||||||
| Balance (in Shares) at Mar. 31, 2025 | 42,280,021 | 454,712,290 | ||||||||||||||||||||||||||
| Investor loan advances and deemed contributions | 268 | 268 | ||||||||||||||||||||||||||
| Subscription proceeds received | 1,500 | 1,500 | ||||||||||||||||||||||||||
| Net loss | $ (40,215) | (40,891) | (40,891) | |||||||||||||||||||||||||
| Balance at Jun. 30, 2025 | $ 12,337 | $ 45 | (324) | (119,779) | (107,721) | |||||||||||||||||||||||
| Balance (in Shares) at Jun. 30, 2025 | 42,280,021 | 454,712,290 | ||||||||||||||||||||||||||
| Balance at Dec. 31, 2025 | $ 26,262 | $ 45 | (2,374) | (678,807) | $ 6 | $ (654,868) | (654,868) | |||||||||||||||||||||
| Balance (in Shares) at Dec. 31, 2025 | 59,671,021 | 454,712,290 | ||||||||||||||||||||||||||
| Reverse recapitalization | (10,872) | (10,872) | (10,872) | |||||||||||||||||||||||||
| Reverse recapitalization (in Shares) | 4,876,199 | |||||||||||||||||||||||||||
| Noncontrolling interests resulting from the Business Combination | $ (13,925) | (13,925) | 13,925 | |||||||||||||||||||||||||
| Noncontrolling interests resulting from the Business Combination (in Shares) | (17,391,000) | |||||||||||||||||||||||||||
| Share issuance upon conversion of convertible preferred units | $ (12,337) | $ 1 | 12,336 | |||||||||||||||||||||||||
| Share issuance upon conversion of convertible preferred units (in Shares) | (42,280,021) | 12,640,000 | ||||||||||||||||||||||||||
| Share issuance upon settlement of the EM Share Obligations | $ 13 | 885,334 | 885,347 | 885,347 | ||||||||||||||||||||||||
| Share issuance upon settlement of the EM Share Obligations (in Shares) | 118,046,178 | |||||||||||||||||||||||||||
| Issuance of common stock for acquisitions | 23,064 | 23,064 | 10 | 23,074 | ||||||||||||||||||||||||
| Issuance of common stock for acquisitions (in Shares) | 3,075,185 | |||||||||||||||||||||||||||
| Investor loan advances and deemed contributions | 1,111 | 1,111 | 1,111 | |||||||||||||||||||||||||
| Reclass of CPU Share Allocation Obligations to equity | 186,766 | 186,766 | 186,766 | |||||||||||||||||||||||||
| Foreign currency translation adjustment | (1,050) | (1,050) | (1,050) | |||||||||||||||||||||||||
| Actuarial (loss) gain on defined severance benefits, net of tax | (18) | (18) | (18) | |||||||||||||||||||||||||
| Net loss | (440,314) | (440,314) | (440,314) | |||||||||||||||||||||||||
| Balance at Mar. 31, 2026 | $ 59 | 908,599 | (1,119,121) | 186,766 | (1,062) | (24,759) | 13,935 | (10,824) | ||||||||||||||||||||
| Balance (in Shares) at Mar. 31, 2026 | 593,349,852 | |||||||||||||||||||||||||||
| Balance at Dec. 31, 2025 | $ 26,262 | $ 45 | (2,374) | (678,807) | 6 | (654,868) | (654,868) | |||||||||||||||||||||
| Balance (in Shares) at Dec. 31, 2025 | 59,671,021 | 454,712,290 | ||||||||||||||||||||||||||
| Net loss | (452,223) | |||||||||||||||||||||||||||
| Balance at Jun. 30, 2026 | $ 62 | 1,113,050 | (1,131,031) | (942) | (18,862) | 10 | (18,852) | |||||||||||||||||||||
| Balance (in Shares) at Jun. 30, 2026 | 621,790,646 | |||||||||||||||||||||||||||
| Balance at Mar. 31, 2026 | $ 59 | 908,599 | (1,119,121) | 186,766 | (1,062) | (24,759) | 13,935 | (10,824) | ||||||||||||||||||||
| Balance (in Shares) at Mar. 31, 2026 | 593,349,852 | |||||||||||||||||||||||||||
| Share issuance upon settlement of the EM Share Obligations | $ 2 | 186,763 | (186,766) | (1) | (1) | |||||||||||||||||||||||
| Share issuance upon settlement of the EM Share Obligations (in Shares) | 24,902,106 | |||||||||||||||||||||||||||
| Foreign currency translation adjustment | (191) | (191) | (191) | |||||||||||||||||||||||||
| Actuarial (loss) gain on defined severance benefits, net of tax | (23) | (23) | (23) | |||||||||||||||||||||||||
| Share issuance upon conversion of convertible preferred units held by noncontrolling interest | $ 1 | 13,924 | 13,925 | (13,925) | ||||||||||||||||||||||||
| Share issuance upon conversion of convertible preferred units held by noncontrolling interest (in Shares) | 2,898,499 | |||||||||||||||||||||||||||
| Share issuance to advisors as consideration for services | 3,445 | 3,445 | 3,445 | |||||||||||||||||||||||||
| Share issuance to advisors as consideration for services (in Shares) | 640,189 | |||||||||||||||||||||||||||
| Investor deemed contributions | 318 | 318 | 318 | |||||||||||||||||||||||||
| Change in fair value of convertible debentures attributed to credit risk | 334 | 334 | 334 | |||||||||||||||||||||||||
| Net loss | (11,910) | (11,910) | (11,910) | |||||||||||||||||||||||||
| Balance at Jun. 30, 2026 | $ 62 | $ 1,113,050 | $ (1,131,031) | $ (942) | $ (18,862) | $ 10 | $ (18,852) | |||||||||||||||||||||
| Balance (in Shares) at Jun. 30, 2026 | 621,790,646 |
| X | ||||||||||
- Definition The amount of actuarial (loss) gain on defined severance benefits, net of tax. No definition available.
|
| X | ||||||||||
- Definition The amount of change in fair value of convertible debentures attributed to credit risk. No definition available.
|
| X | ||||||||||
- Definition The amount of investor deemed contributions. No definition available.
|
| X | ||||||||||
- Definition The amount of reclass of CPU share allocation obligations to equity. No definition available.
|
| X | ||||||||||
- Definition The amount of reverse recapitalization. No definition available.
|
| X | ||||||||||
- Definition The amount of share issuance upon conversion of convertible preferred units. No definition available.
|
| X | ||||||||||
- Definition The amount of share issuance upon conversion of convertible preferred units held by noncontrolling interest. No definition available.
|
| X | ||||||||||
- Definition Number of share issuance upon conversion of convertible preferred units held by noncontrolling interest. No definition available.
|
| X | ||||||||||
- Definition The shares noncontrolling interests resulting from the Business Combination. No definition available.
|
| X | ||||||||||
- Definition The amount of shares issued during non controlling interest. No definition available.
|
| X | ||||||||||
- Definition Number of shares of share issuance upon conversion of convertible preferred units. No definition available.
|
| X | ||||||||||
- Definition the amount of subscription proceeds received. No definition available.
|
| X | ||||||||||
- Definition Amount of other increase (decrease) in additional paid in capital (APIC). No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares of stock issued attributable to transactions classified as other. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Value of stock issued pursuant to acquisitions during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|